Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR.
暂无分享,去创建一个
M. Jinzaki | M. Murata | K. Fukuda | Makoto Tanaka | Yuichiro Maekawa | M. Sano | Yoshitake Yamada | R. Yanagisawa | K. Hayashida | Fumiaki Yashima | T. Inohara | T. Arai | T. Kawakami | H. Tsuruta | Y. Itabashi | K. Okamoto | Akihiro Yoshitake | H. Shimizu | Takashi Kawakami | F. Yashima | Takahide Arai
[1] J. Leipsic,et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. , 2016, European heart journal.
[2] Patricia A Pellikka,et al. Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. , 2015, Journal of the American College of Cardiology.
[3] O. Gürsoy,et al. Sixty-Four–Section Cardiac Computed Tomography in Mechanical Prosthetic Heart Valve Dysfunction: Thrombus or Pannus , 2015, Circulation. Cardiovascular imaging.
[4] Deepak L. Bhatt,et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. , 2015, The New England journal of medicine.
[5] F. Neumann,et al. Early hypoattenuated leaflet thickening and restricted leaflet motion of a Lotus transcatheter heart valve detected by 4D computed tomography angiography. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[6] Yoshinobu Onuma,et al. Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[8] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[9] R. Virmani,et al. Thrombus formation following transcatheter aortic valve replacement. , 2015, JACC. Cardiovascular interventions.
[10] J. Leipsic,et al. Early Aortic Transcatheter Heart Valve Thrombosis: Diagnostic Value of Contrast-Enhanced Multidetector Computed Tomography , 2015, Circulation. Cardiovascular interventions.
[11] D. Mylotte,et al. Transcatheter aortic valve replacement failure: déjà vu ou jamais vu? , 2015, Circulation. Cardiovascular interventions.
[12] O. Alfieri,et al. Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis , 2015, Circulation. Cardiovascular interventions.
[13] H. Jilaihawi,et al. Major thrombocytopenia after balloon‐expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[14] G. Pache,et al. Valve thrombosis 7 months after transcatheter aortic valve implantation. , 2014, Annals of Thoracic Surgery.
[15] M. Desai,et al. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement. , 2014, The Journal of thoracic and cardiovascular surgery.
[16] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[17] P. Blanke,et al. Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. , 2013, European heart journal.
[18] O. Alfieri,et al. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. , 2013, Journal of the American College of Cardiology.
[19] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[20] Hiroaki Sugiura,et al. Dose reduction in chest CT: comparison of the adaptive iterative dose reduction 3D, adaptive iterative dose reduction, and filtered back projection reconstruction techniques. , 2012, European journal of radiology.
[21] Sean M. O'Brien,et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. , 2012, Journal of the American College of Cardiology.
[22] Susheel Kodali,et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. , 2012, The New England journal of medicine.
[23] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[24] P. Serruys,et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study , 2010, European heart journal.
[25] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[26] Fabien Hyafil,et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. , 2010, Journal of the American College of Cardiology.
[27] P. Pibarot,et al. Prosthetic Heart Valves Selection of the Optimal Prosthesis and Long-Term Management , 2009 .